New flexible MRI coil could spare men unnecessary prostate biopsies

NCT ID NCT05043012

Recruiting now Diagnosis Sponsor: M.D. Anderson Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Aug 14, 2026 · Updated 2 times

Summary

This study is testing whether a new flexible MRI coil can accurately detect significant prostate cancer in 258 men with intermediate or high-risk disease. The goal is to see if this less invasive approach can reduce the number of unnecessary biopsies. Participants will receive both the standard and the new MRI scan to compare results.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: flexible AIR coil
What this could lead to: If successful, this could make prostate MRI scans more comfortable and accessible, potentially reducing the need for invasive biopsies.
What could go wrong: This is an early-stage diagnostic study, not a treatment trial. The new coil may not be as accurate as the standard endorectal coil, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTERMEDIATE AND HIGH-RISK PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer prostate carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

The University of Texas MD Anderson Cancer Center
RECRUITING

Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.